Experiment 815503
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | MURPHY,WK: LIVINGSTON,RB: GOTTLIEB,JA: BURGESS,MA: RAWSON,RW:. (1976). PHASE I EVALUATION OF ANGUIDINE.. 17() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I CLINICAL STUDY IN 19 PATIENTS SIDE EFFECTS:NAUSEA,VOMITING,WEAKNESS,CONFUSION,DYSARTHRIA,GLOMERULAR DAMAGE |
| Dose amount | 5.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |